Market Closed -
Borsa Istanbul
11:09:18 2024-05-28 EDT
|
5-day change
|
1st Jan Change
|
9.65
TRY
|
+9.91%
|
|
+20.93%
|
+133.09%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
26.97
|
29.09
|
291.1
|
217.7
|
993.7
|
1,035
|
Enterprise Value (EV)
1 |
28.13
|
37
|
329.1
|
332
|
1,316
|
1,748
|
P/E ratio
|
5.94
x
|
4.31
x
|
14.5
x
|
17.7
x
|
9.31
x
|
4.19
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.54
x
|
0.17
x
|
0.81
x
|
0.39
x
|
0.65
x
|
0.25
x
|
EV / Revenue
|
0.56
x
|
0.22
x
|
0.91
x
|
0.59
x
|
0.86
x
|
0.43
x
|
EV / EBITDA
|
3.94
x
|
3.17
x
|
26.1
x
|
13.1
x
|
7.69
x
|
2.39
x
|
EV / FCF
|
-3.92
x
|
17.4
x
|
-4.82
x
|
-1.7
x
|
-4.88
x
|
-6.66
x
|
FCF Yield
|
-25.5%
|
5.76%
|
-20.8%
|
-58.8%
|
-20.5%
|
-15%
|
Price to Book
|
1.36
x
|
1.1
x
|
4.85
x
|
1.15
x
|
2.81
x
|
0.83
x
|
Nbr of stocks (in thousands)
|
48,037
|
48,037
|
96,074
|
96,074
|
125,000
|
250,000
|
Reference price
2 |
0.5615
|
0.6055
|
3.030
|
2.266
|
7.950
|
4.140
|
Announcement Date
|
19-03-01
|
20-03-02
|
21-03-01
|
22-03-10
|
23-03-10
|
24-04-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
50.37
|
169.4
|
360.1
|
564.7
|
1,537
|
4,087
|
EBITDA
1 |
7.131
|
11.67
|
12.59
|
25.37
|
171.1
|
731.8
|
EBIT
1 |
6.981
|
11.08
|
11.52
|
21.91
|
160.8
|
688.8
|
Operating Margin
|
13.86%
|
6.54%
|
3.2%
|
3.88%
|
10.46%
|
16.85%
|
Earnings before Tax (EBT)
1 |
6.062
|
8.861
|
21.28
|
13.77
|
111.7
|
191.2
|
Net income
1 |
4.54
|
6.747
|
20.04
|
15.97
|
106.7
|
247
|
Net margin
|
9.01%
|
3.98%
|
5.57%
|
2.83%
|
6.94%
|
6.04%
|
EPS
2 |
0.0945
|
0.1405
|
0.2086
|
0.1277
|
0.8537
|
0.9881
|
Free Cash Flow
1 |
-7.18
|
2.132
|
-68.33
|
-195.2
|
-269.7
|
-262.6
|
FCF margin
|
-14.25%
|
1.26%
|
-18.98%
|
-34.57%
|
-17.55%
|
-6.43%
|
FCF Conversion (EBITDA)
|
-
|
18.26%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
31.59%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-01
|
20-03-02
|
21-03-01
|
22-03-10
|
23-03-10
|
24-04-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1.15
|
7.91
|
38
|
114
|
322
|
713
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.1619
x
|
0.678
x
|
3.017
x
|
4.504
x
|
1.882
x
|
0.9746
x
|
Free Cash Flow
1 |
-7.18
|
2.13
|
-68.3
|
-195
|
-270
|
-263
|
ROE (net income / shareholders' equity)
|
25.9%
|
29.1%
|
46.3%
|
10.4%
|
35.6%
|
23.9%
|
ROA (Net income/ Total Assets)
|
16.5%
|
9.46%
|
4.37%
|
3.25%
|
9.13%
|
13.1%
|
Assets
1 |
27.45
|
71.3
|
458.3
|
491.4
|
1,169
|
1,881
|
Book Value Per Share
2 |
0.4100
|
0.5500
|
0.6200
|
1.970
|
2.830
|
5.000
|
Cash Flow per Share
2 |
0.0100
|
0.1100
|
0.0300
|
0.0300
|
0.3500
|
0.0600
|
Capex
1 |
2.78
|
3.22
|
17.9
|
37.6
|
119
|
202
|
Capex / Sales
|
5.53%
|
1.9%
|
4.98%
|
6.66%
|
7.74%
|
4.93%
|
Announcement Date
|
19-03-01
|
20-03-02
|
21-03-01
|
22-03-10
|
23-03-10
|
24-04-25
|
|
1st Jan change
|
Capi.
|
---|
| +133.09% | 68.22M | | +3.08% | 104B | | -10.06% | 61.03B | | +72.86% | 47.64B | | +17.31% | 39.24B | | +3.82% | 32.09B | | +13.58% | 20.39B | | +13.81% | 16.85B | | +11.47% | 14.28B | | -0.10% | 13.88B |
Other Commodity Chemicals
|